These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 37076817)

  • 1. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
    Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
    Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
    Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
    J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.
    Perre SV; Duron L; Milon A; Bekhouche A; Balvay D; Cornelis FH; Fournier L; Thomassin-Naggara I
    Eur Radiol; 2021 Jul; 31(7):4848-4859. PubMed ID: 33404696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging.
    Liu C; Wang K; Chan Q; Liu Z; Zhang J; He H; Zhang S; Liang C
    Eur Radiol; 2016 Nov; 26(11):3888-3898. PubMed ID: 26863896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Volumetric Perfusion Quantitative Parameters Using CS-VIBE Breast Dynamic Contrast Enhanced MR Imaging.
    Chang YW; Lee EJ; Hwang J; Nickel D; Sung JK
    Curr Med Imaging; 2023; 19(11):1286-1294. PubMed ID: 36165524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
    Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pharmacokinetic parameters derived with high temporal resolution DCE MRI using simultaneous PET/MRI system in breast cancer: A feasibility study.
    Jena A; Taneja S; Singh A; Negi P; Mehta SB; Sarin R
    Eur J Radiol; 2017 Jan; 86():261-266. PubMed ID: 28027758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
    Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
    J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer.
    Zhou X; Gao F; Duan S; Zhang L; Liu Y; Zhou J; Bai G; Tao W
    Phys Eng Sci Med; 2020 Jun; 43(2):517-524. PubMed ID: 32524436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
    Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
    Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.